# Combination of Efavirenz and Truvada - COMET Study

> **NCT00224458** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 400 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Truvada
- **DRUG:** efavirenz

## Key facts

- **NCT ID:** NCT00224458
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 400 (—)
- **Last updated:** 2008-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224458, "Combination of Efavirenz and Truvada - COMET Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00224458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*